Reading Time: 6 minutesThe results of the MIROCALS clinical trial into the effects of low dose interleukin-2 (IL-2) on people with MND have now been published in The
Tag: MIROCALS
Reading Time: 5 minutesThe MND clinical trial landscape has grown vastly over the last decade and this has led to increased opportunities for people with MND to take
Reading Time: 6 minutesEach year, MND Associations across the globe mark 21 June as a special day of recognition, acknowledging the impact that MND has on people around
Reading Time: 4 minutesAlthough ALS is a neurodegenerative disease, researchers are increasingly also interested in events happening outside the brain and spinal cord, in particular whether changes in
Reading Time: 4 minutesExploring the link between our guts and our general health is becoming increasingly popular. Studies of people with various physical and mental health conditions suggest
Reading Time: 7 minutesIs it possible that a drug that treats congestive heart failure could improve respiration in people with MND? Or that a drug used to treat
Reading Time: 4 minutesConferences and symposia are a crucial part of the research world – not only for the amount of knowledge that is communicated to large audiences
Reading Time: 5 minutesA clinical trial of Jedi proportions… The MND Association is backing a new clinical trial in MND, known as MIROCALS. This will be a joint